Emergent Biosolutions Financials

Values in thousands	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	$148,700	$231,100	$140,900	$222,200
Gross Profit	31,100	139,400	60,700	119,400
EBITDA	6,900	96,200	23,500	75,200
EBIT	-16,600	72,800	500	50,400
Net Income	-54,600	51,200	-12,000	68,000
Net Change In Cash	148,700	231,100	140,900	222,200
Free Cash Flow	73,800	-5,700	103,500	-14,800
Cash	205,400	245,500	271,000	149,100
Basic Shares	56,700	56,500	54,200	57,300

Values in thousands	2025-12-31	2024-12-31	2023-12-31	2022-12-31
Revenue	$742,900	$1,043,599	$1,049,300	$1,120,900
Gross Profit	350,600	375,400	360,000	427,200
EBITDA	208,500	53,400	-47,000	-34,400
EBIT	110,200	-52,200	-168,100	-166,000
Net Income	52,600	-190,600	-760,500	-223,800
Net Change In Cash	742,900	1,043,599	1,049,300	1,120,900
Cost of Revenue				65,800
Free Cash Flow	156,800	35,800	-257,900	-149,900
Cash	205,400	99,500	111,700	642,600
Basic Shares	56,700	53,000	51,200	50,100